Literature DB >> 30501865

Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance.

Oliver Ottmann1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30501865     DOI: 10.1016/S2352-3026(18)30181-9

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN: 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  2 in total

Review 1.  New Approaches to Treating Challenging Subtypes of ALL in AYA Patients.

Authors:  Kevin Prescott; Michael Jacobs; Wendy Stock; Joseph Wynne
Journal:  Curr Hematol Malig Rep       Date:  2020-12       Impact factor: 3.952

2.  Clinical Outcome in Pediatric Patients with Philadelphia Chromosome Positive ALL Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy-The Experience of a Polish Pediatric Leukemia and Lymphoma Study Group.

Authors:  Joanna Zawitkowska; Monika Lejman; Marcin Płonowski; Joanna Bulsa; Tomasz Szczepański; Michał Romiszewski; Agnieszka Mizia-Malarz; Katarzyna Derwich; Grażyna Karolczyk; Tomasz Ociepa; Magdalena Ćwiklińska; Joanna Trelińska; Joanna Owoc-Lempach; Ninela Irga-Jaworska; Anna Małecka; Katarzyna Machnik; Justyna Urbańska-Rakus; Radosław Chaber; Jerzy Kowalczyk; Wojciech Młynarski
Journal:  Cancers (Basel)       Date:  2020-12-13       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.